Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Patient-perceived risks of MS DMTs: Problems of communication and risk management?

McDonnell GV, Marriott JJ.

Neurology. 2019 Apr 2;92(14):647-648. doi: 10.1212/WNL.0000000000007230. Epub 2019 Mar 13. No abstract available.

PMID:
30867263
2.

Diet in multiple sclerosis: Science takes a seat at the table.

Sumowski JF, McDonnell GV, Bourdette D.

Neurology. 2018 Jan 2;90(1):14-15. doi: 10.1212/WNL.0000000000004775. Epub 2017 Dec 6. No abstract available.

PMID:
29212826
3.

Comorbidities in MS are associated with treatment intolerance and disability.

McDonnell GV, Cohen JA.

Neurology. 2017 Nov 28;89(22):2218-2219. doi: 10.1212/WNL.0000000000004699. Epub 2017 Nov 1. No abstract available.

PMID:
29093072
4.

A rare characteristic neuroimaging pattern in hyperammonaemia.

Kinney MO, McDonnell GV, McConville J, McCarron MO, McKenna E.

Ulster Med J. 2017 Jan;86(1):28-30. No abstract available.

5.

Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

McDonnell GV, Bennett A, Rae-Grant A, Bever C.

Neurology. 2016 Apr 5;86(14):1361. doi: 10.1212/WNL.0000000000002578. No abstract available.

PMID:
27044615
6.

Acute neuromuscular respiratory failure: a population-based study of aetiology and outcome in Northern Ireland.

Carr AS, Hoeritzauer AI, Kee R, Kinney M, Campbell J, Hutchinson A, McDonnell GV.

Postgrad Med J. 2014 Apr;90(1062):201-4. doi: 10.1136/postgradmedj-2013-132105. Epub 2014 Feb 17.

PMID:
24534488
7.

Paraneoplastic sensorimotor neuropathy associated with regression of small cell lung carcinoma.

Mawhinney E, Gray OM, McVerry F, McDonnell GV.

BMJ Case Rep. 2010 Oct 3;2010. pii: bcr0120091486. doi: 10.1136/bcr.01.2009.1486.

8.

Transient cardiomyopathy as the presenting feature of acute disseminated encephalomyelitis.

Mawhinney E, Watt M, McDonnell GV.

Mult Scler. 2009 Dec;15(12):1534-6. doi: 10.1177/1352458509348518.

PMID:
20019097
9.

An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.

Gray OM, Abdeen H, McDonnell GV, Patterson CC, Graham CA, Hawkins SA.

Mult Scler. 2009 Mar;15(3):299-303. doi: 10.1177/1352458508099611.

PMID:
19244395
10.

Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.

Gray O, McDonnell G, Hawkins S.

Mult Scler. 2009 Jan;15(1):75-80. doi: 10.1177/1352458508096872. Epub 2008 Oct 1.

PMID:
18829636
11.

Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.

Gray OM, McDonnell GV, Hawkins SA.

Mult Scler. 2008 Aug;14(7):880-6. doi: 10.1177/1352458508090663. Epub 2008 Jun 23.

PMID:
18573832
12.

Opsoclonus-myoclonus syndrome associated with benign ovarian teratoma.

Fitzpatrick AS, Gray OM, McConville J, McDonnell GV.

Neurology. 2008 Apr 8;70(15):1292-3. doi: 10.1212/01.wnl.0000308947.70045.7a. No abstract available.

PMID:
18391162
13.

A systematic review of oral methotrexate for multiple sclerosis.

Gray OM, McDonnell GV, Forbes RB.

Mult Scler. 2006 Aug;12(4):507-10. Review.

PMID:
16900766
14.

Mapping candidate non-MHC susceptibility regions to multiple sclerosis.

Abdeen H, Heggarty S, Hawkins SA, Hutchinson M, McDonnell GV, Graham CA.

Genes Immun. 2006 Sep;7(6):494-502. Epub 2006 Jul 13.

PMID:
16837933
15.

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA.

Neurology. 2005 Apr 12;64(7):1144-51.

PMID:
15824338
16.

Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.

Silversides JA, Heggarty SV, McDonnell GV, Hawkins SA, Graham CA.

Mult Scler. 2004 Apr;10(2):149-52.

PMID:
15124759
17.

Methotrexate for multiple sclerosis.

Gray O, McDonnell GV, Forbes RB.

Cochrane Database Syst Rev. 2004;(2):CD003208. Review.

PMID:
15106195
18.

Intravenous immunoglobulins for multiple sclerosis.

Gray O, McDonnell GV, Forbes RB.

Cochrane Database Syst Rev. 2003;(4):CD002936. Review.

PMID:
14583956
19.

A bed bound patient.

Hanna GG, McDonnell GV.

Postgrad Med J. 2003 Jul;79(933):418, 421-3. No abstract available.

20.

Post-operative hyperkalaemic paralysis.

Beattie GC, McDonnell GV, Wilkinson AJ, Maxwell RJ.

Ulster Med J. 2003 May;72(1):61-3. No abstract available.

22.

Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae.

Kerr JR, Barah F, Chiswick ML, McDonnell GV, Smith J, Chapman MD, Bingham JB, Kelleher P, Sheppard MN.

J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):739-46.

23.

A bad dose of 'flu.

McDonnell GV.

Postgrad Med J. 2002 Jun;78(920):373, 377-8. No abstract available.

24.

Primary progressive multiple sclerosis: increasing clarity but many unanswered questions.

McDonnell GV, Hawkins SA.

J Neurol Sci. 2002 Jul 15;199(1-2):1-15. Review.

PMID:
12084436
25.

Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis.

Boylan MT, Crockard AD, McDonnell GV, McMillan SA, Hawkins SA.

Immunol Lett. 2001 Oct 1;78(3):183-7.

PMID:
11578693
26.
27.

Human immunoglobulin for diabetic amyotrophy--a promising prospect?

Courtney AE, McDonnell GV, Patterson VH.

Postgrad Med J. 2001 May;77(907):326-8. Review.

28.

An unusual case of ataxia.

Murtagh E, McDonnell GV, Hawkins SA, McKinstry CS.

Clin Radiol. 2001 Mar;56(3):247-9. Review. No abstract available.

PMID:
11247705
29.

Why do adults with spina bifida and hydrocephalus die? A clinic-based study.

McDonnell GV, McCann JP.

Eur J Pediatr Surg. 2000 Dec;10 Suppl 1:31-2.

PMID:
11214829
30.

Prevalence of the Chiari/hydrosyringomyelia complex in adults with spina bifida: preliminary results.

McDonnell GV, McCann JP, Craig JJ, Crone M.

Eur J Pediatr Surg. 2000 Dec;10 Suppl 1:18-9.

PMID:
11214825
31.

Multiple sclerosis in Northern Ireland: a historical and global perspective.

McDonnell GV, Hawkins SA.

Ulster Med J. 2000 Nov;69(2):97-105.

32.

Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis.

Kirk CW, Graham CA, McDonnell GV, Hawkins SA.

Mult Scler. 2000 Aug;6(4):291-2. No abstract available.

PMID:
10962551
33.

Link between the CSF shunt and achievement in adults with spina bifida.

McDonnell GV, McCann JP.

J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):800. No abstract available.

34.

An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis.

McDonnell GV, Kirk CW, Hawkins SA, Graham CA.

J Neurol Sci. 2000 May 1;176(1):4-12.

PMID:
10865086
35.

Issues of medical management in adults with spina bifida.

McDonnell GV, McCann JP.

Childs Nerv Syst. 2000 Apr;16(4):222-7.

PMID:
10855520
36.

Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.

McMillan SA, McDonnell GV, Douglas JP, Hawkins SA.

Acta Neurol Scand. 2000 Apr;101(4):239-43.

PMID:
10770519
37.

Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis.

McDonnell GV, Kirk CW, Middleton D, Droogan AG, Hawkins SA, Patterson CC, Graham CA.

J Neurol. 1999 Nov;246(11):1051-8.

PMID:
10631637
38.

A pain in the neck.

McDonnell GV, Bell KE, Hawkins SA.

Postgrad Med J. 2000 Jan;76(891):57-60. No abstract available.

40.

Major histocompatibility complex class II alleles and the course and outcome of MS.

McDonnell GV, Hawkins SA.

Neurology. 1999 Sep 11;53(4):893-4. No abstract available.

PMID:
10489071
41.

A homesick student.

McDonnell GV, Esmonde TF.

Postgrad Med J. 1999 Jun;75(884):375-8. No abstract available.

42.

A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.

McDonnell GV, Mawhinney H, Graham CA, Hawkins SA, Middleton D.

J Neurol Sci. 1999 May 1;165(1):77-83.

PMID:
10426152
43.

Relationship between tumour necrosis factor-alpha (TNFalpha) production and a specific multiple sclerosis (MS) associated TNF gene haplotype.

Armstrong MA, McDonnell GV, Graham CA, Kirk CW, Droogan AG, Hawkins SA.

Mult Scler. 1999 Jun;5(3):165-70.

PMID:
10408716
44.

Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.

Hawkins SA, McDonnell GV.

J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):148-52.

45.
46.

Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease.

McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA.

J Neurol. 1999 Feb;246(2):87-92.

PMID:
10195402
47.

High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition.

McDonnell GV, Hawkins SA.

J Neurol Neurosurg Psychiatry. 1999 Mar;66(3):411. No abstract available.

48.

Elevated serum and CSF levels of soluble CD30 during clinical remission in multiple sclerosis.

McMillan SA, McDonnell GV, Douglas JP, Droogan AG, Hawkins SA.

Neurology. 1998 Oct;51(4):1156-60.

PMID:
9781547
49.

Raised CSF levels of soluble adhesion molecules across the clinical spectrum of multiple sclerosis.

McDonnell GV, McMillan SA, Douglas JP, Droogan AG, Hawkins SA.

J Neuroimmunol. 1998 May 15;85(2):186-92.

PMID:
9630167
50.

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK.

McDonnell GV, Hawkins SA.

J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):451-4.

Supplemental Content

Loading ...
Support Center